Aptose Biosciences, Inc. (NASDAQ:APTO) a clinical-stage biotechnology company, is expected to report third quarter earnings results, after market close, on Tuesday 10th November 2020.
Stock Performance
Shares of Aptose Biosciences, Inc. traded up $ 0.01 or 0.11 percent on Monday, reaching $ 4.51 with volume of 792.80 thousand shares. Aptose Biosciences, Inc. has traded high as $ 4.73 and has cracked $ 4.48 on the downward trend
According to the previous trading day, closing price of $ 4.51, representing a 94.40 % increase from the 52 week low of $ 2.32 and a 51.24 % decrease over the 52 week high of $ 9.25.
The company has a market capital of $ 391.54 million and is part of the Healthcare sector and Biotechnology industry.
Conference Call
Aptose Biosciences, Inc. will be hosting a conference call at 5:00 PM eastern time on 10th November 2020, to discuss its 3Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.aptose.com
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in the United States. Its clinical programs is APTO-253, which is a Phase Ib clinical trial for the treatment of patients with relapsed/refractory blood cancers, including acute myeloid leukemia and high-risk myelodysplastic syndrome. It has an agreement with CrystalGenomics, Inc.
